New combination therapy for pancreatic carcinomas and colon cancer
The current invention is based on combination therapies of nucleoside analogs with inhibitors of either the Nodal/Activin pathway or the mTOR / hedgehog pathway and show a remarkable capacity to eliminate cancer stem cells
and to subsequently inhibit pancreatic and/or colon cancer.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All news from this category: Technology Offerings
Latest posts
Novel chirped pulses defy ‘conventional wisdom’
University of Rochester researchers describe first highly chirped pulses created by a using a spectral filter in a Kerr resonator. The 2018 Nobel Prize in Physics was shared by researchers…
Scientists design superfast molecular motor
Light-driven molecular motors have been around for over twenty years. These motors typically take microseconds to nanoseconds for one revolution. Thomas Jansen, associate professor of physics at the University of…
Changing a 2D material’s symmetry can unlock its promise
Jian Shi Research Group engineers material into promising optoelectronic. Optoelectronic materials that are capable of converting the energy of light into electricity, and electricity into light, have promising applications as…
